Outcome Leadership
President and Chief Executive Officer
Richard Gliklich, MD
Dr. Richard Gliklich is President and Chief Executive Officer of Outcome. Dr. Gliklich is a pioneer in the field of registries – strategy, tactics and technology-- and has led Outcome since its inception in 1998.
Dr. Gliklich focuses on post-approval research programs, particularly observational research on effectiveness, safety and quality of care. Some of the programs developed by Dr. Gliklich include the American Heart Association’s Get With The GuidelinesSM registries in cardiovascular disease, heart failure, and stroke, which involve more than 2,500 U.S. hospitals and more than one million patients, and received the 2004 Innovation Award from the Department of Health and Human Services. He has also worked extensively in the area of information technology for post-approval research and is a member of the American Heart Association’s Heart IT Task force. He is a Principal Investigator (PI) for the Outcome DEcIDE Center, one of 13 DEcIDE centers under the Agency for Healthcare Research and Quality’s Effective Healthcare Program. Dr. Gliklich is an author and senior editor of the Agency for Healthcare Research and Quality (AHRQ) handbook “Registries for Evaluating Patient Outcomes: A User’s Guide.”
Dr. Gliklich did his undergraduate work at Yale University and completed his medical training at Harvard Medical School. He trained in Outcomes Research as a Charles A. Dana Scholar at the University of Pennsylvania School of Medicine. Dr. Gliklich is a frequently invited speaker on post-approval programs and registries, and has served on numerous advisory boards. He is the director of an annual international conference at Harvard, focusing on post-approval studies, registries and risk management (Post-Approval Summit at Harvard). He has authored more than 70 academic publications, including articles about medical conditions of the head and neck, as well as articles on registries. Dr. Gliklich is the editor of a textbook on the practical value of real-world clinical data in medical practice, “Profiting from Quality: Outcomes strategies for medical practice,” published by Jossey-Bass, Inc., in 1999. In addition to his work at Outcome, Dr. Gliklich maintains an active medical practice and is an Associate Professor at Harvard Medical School.
Chief of Scientific Affairs and Senior Vice President
Nancy Dreyer, MPH, PhD
Nancy Dreyer is Chief of Scientific Affairs for Outcome. Dr. Dreyer has more than 20 years of experience in the design, conduct and interpretation of pharmacoepidemiologic research. At Outcome, she leads a team of epidemiologists, biostatisticians and clinical program designers who work together on observational research and quality improvement programs. She is the Project Director for Outcome’s DEcIDE Center for the Agency for Healthcare Research and Quality (AHRQ). Under this program, Outcome and Dr. Dreyer, as a senior editor and author, led the creation of the AHRQ handbook, “Registries for Evaluating Patient Outcomes: A User’s Guide,” a reference for the creation, execution and evaluation of registries.
Dr. Dreyer trained at the University of North Carolina in Chapel Hill, earning a masters degree and doctorate in epidemiology, and was named a Fellow of the International Society of Pharmacoepidemiology in 2003. Her credentials include working as CEO of Epidemiology Resources Inc. from its inception through its acquisition 20 years later by UnitedHealth; directing an internationally renowned postgraduate summer epidemiology program in collaboration with Tufts Medical School and Boston University School of Public Health; and launching the peer-reviewed journal, Epidemiology. At UnitedHealth Group, Dr. Dreyer spent 5 years in various senior management positions in the epidemiology, outcomes and the CRO divisions of Ingenix, a wholly owned subsidiary of UnitedHealth. She has more than 60 publications, and has mentored many more.
In addition to her work at Outcome, Dr. Dreyer has been a director of the Drug Research Group since 1993. She is a member of the Brandeis University Board of Overseers for the Heller School for Social Policy and Management, and the University of North Carolina School of Public Health Dean’s Advisory Council. She served as a Consumer Representative to the FDA for 4 years in radiopharmaceuticals, and has served on advisory committees for industry and trade associations.
Chief Operating Officer and Senior Vice President
Bob Kaufman, MBA
Bob Kaufman joined Outcome in 2007 as its Chief Operating Officer. He brings more than 25 years of experience in the healthcare industry to the company. Prior to joining Outcome, Bob was the co-founder and Chief Executive Officer of a venture backed healthcare services and technology company, which was successfully sold to a provider of specialized outpatient information solutions and services. He was responsible for overseeing the development of a highly complex technology platform for the capture, reading, and delivery of DICOM images and files to specialty practice based and primary care physicians. Bob has served as the Chief Executive Officer of one of the largest senior housing companies in the United States. He also spent more than 24 years at PriceWaterhouseCoopers, where he was responsible for the service to companies in all segments of the healthcare industry, including advice and consultation in the areas of strategic and long-term planning, operational efficiencies, mergers and acquisitions and corporate restructurings. In addition, Bob served on its Board of Partners, an elected body of partners that was responsible for the oversight and direction of the firm. Bob received his MBA from Cornell University and his BA from Colby College.